Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes

Hypereosinophilic syndromes (HESs) are a heterogeneous group of disorders characterized by peripheral eosinophilia and eosinophil-related end organ damage. Whereas most patients respond to glucocorticoid (GC) therapy, high doses are often necessary, and side effects are common. Dexpramipexole (KNS-7...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Panch, Sandhya R., Bozik, Michael E., Brown, Thomas, Makiya, Michelle, Prussin, Calman, Archibald, Donald G., Hebrank, Gregory T., Sullivan, Mary, Sun, Xiaoping, Wetzler, Lauren, Ware, JeanAnne, Fay, Michael P., Dunbar, Cynthia E., Dworetzky, Steven I., Khoury, Paneez, Maric, Irina, Klion, Amy D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6073324/
https://ncbi.nlm.nih.gov/pubmed/29739754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-02-835330
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados